Esperion Therapeutics, Inc. (ESPR) NASDAQ

1.09

+0.106(+10.77%)

Updated at May 02 04:00PM

Currency In USD

Valuation

Market Cap411.8M
Enterprise Value564.64M
P/E Ratio-4.02
PEG Ratio-0.06
Price/Sales Ratio0.65
Price/Book Ratio-0.54
Enterprise/Revenue1.11
Enterprise/EBITDA48.73

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-0.16
Operating Margin0.16

Management Effectiveness

Return On Assets-0.15
Return On Equity0.15

Income Statement

Revenue332.31M
Revenue/Share1.74
Gross Profit263.71M
EBITDA7.57M
Net Income-51.75M
Diluted EPS-0.28

Balance Sheet

Total Cash144.76M
Total Cash/Share0.76
Total Debt297.6M
Total Debt/Equity-0.77
Current Ratio1.37
Book Value Per Share-2.03

Price History

52-Week Change-47.6
52-Week High3.94
52-Week Low0.82
Moving Average 50 Days1.36
Moving Average 200 Days1.93

Statistics

Average Volume4.42M
Shares Outstanding198.15M
% Held by Institutions64.65

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A